Company intelligence / Profile preview

Cellerix S.A.

Tres Cantos, Madrid, Spaincellerix.com ↗

Ownership: Private
Employees: ~7
Development stage: Other

Overview

Positive Phase IIa data for Cx601 for the treatment of complex perianal fistula in Crohn's disease patients in 2010. Authorization to start a Phase I/II trial for Cx611 in rheumatoid arthritis.

Therapeutic areas: GastroenterologyImmunology
Modalities: Adult stem cellsexpanded adult stem cells from adipose tissue (eASCs)
Industry: Biotech

Beyond the preview

Go deeper on Cellerix S.A..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellerix S.A..